Associations of Three-Dimensional Anthropometric Body Surface Scanning Measurements and Coronary Artery Disease

: The relationship between three-dimensional (3D) scanning-derived body surface measurements and biomarkers in patients with coronary artery disease (CAD) were assessed. : The recruitment of 98 patients with CAD confirmed by cardiac catheterization and 98 non-CAD patients were performed between March 2016 and December 2017. A health questionnaire on basic information, life style variables, and past medical and family history was completed. 3D body surface measurements and biomarkers were obtained. Differences between the two groups were assessed and multivariable analysis performed. : It was found that chest width (odds ratio [OR] 0.761, 95% confidence interval [CI] = 0.586-0.987, = 0.0399), right arm length (OR 0.743, 95% CI = 0.632-0.875, = 0.0004), waist circumference (OR 1.119, 95% CI = 1.035-1.21, = 0.0048), leptin (OR 1.443, 95% CI = 1.184-1.76, = 0.0003), adiponectin (OR 0.978, 95% CI = 0.963-0.994, = 0.006), and interleukin 6 (OR 1.181, 95% CI = 1.021-1.366, = 0.0254) were significantly associated with CAD. The combination of biomarker scores and body measurement scores had the greatest area under the curve and best association with CAD (area under the curve of 0.8049 and 95% CI = 0.7440-0.8657). Conclusions: Our study suggests that 3D derived body surface measurements in combination with leptin, adiponectin, and interleukin 6 levels may direct us to those at risk of CAD, allowing a non-invasive approach to identifying high-risk patients.